Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma

Ming Whei Yu; Shu Wen Cheng; Ming Wei Lin; Shi Yi Yang; Yun Fan Liaw; Hung Chuen Chang; Tun Jen Hsiao; Shi Ming Lin; Shou Dong Lee; Pei Jer Chen; Chun Jen Liu; Chien Jen Chen

doi:10.1093/jnci/92.24.2023

Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma

Ming Whei Yu^*, Shu Wen Cheng, Ming Wei Lin, Shi Yi Yang, Yun Fan Liaw, Hung Chuen Chang, Tun Jen Hsiao, Shi Ming Lin, Shou Dong Lee, Pei Jer Chen, Chun Jen Liu, Chien Jen Chen

^*Corresponding author for this work

School of Medicine

Research output: Contribution to journal › Journal Article › peer-review

134 Scopus citations

Abstract

Background: Worldwide, hepatocellular carcinoma (HCC) is more prevalent in men than in women, suggesting that sex hormones and/or X-chromosome-linked genes may be involved in hepatocarcinogenesis. We investigated the association of a trinucleotide (CAG) repeat in the androgen receptor (AR) gene (located on the X chromosome) termed "AR-CAG repeats," levels of plasma testosterone, and the risk of HCC in Taiwanese men. Chronic hepatitis B virus (HBV) infection, which is associated with risk of HCC, is hyperendemic in Taiwan. Methods: We compared the number of AR-CAG repeats in 285 HBV carriers with HCC and in 349 HBV carriers without HCC. We also conducted a nested case-control study on participants in a cohort study. Blood was collected prospectively from 110 case patients and 239 control subjects and was used to determine the number of AR-CAG repeats and plasma testosterone level. All statistical tests were two-sided. Results: The overall odds ratio (OR) for HCC was 1.72 (95% confidence interval [CI] = 1.03-2.89) for HBV carriers with 20 or fewer AR-CAG repeats compared with those with more than 24 repeats. This association was observed only in patients with late-onset HCC (OR = 2.37; 95% CI = 1.28-4.38). In the nested case-control study, HBV carriers in the highest tertile of testosterone levels had a statistically significantly increased risk of HCC (OR = 2.06; 95% CI = 1.14-3.70) compared with those in the lowest tertile. Elevated testosterone was more strongly associated with early-onset (OR = 4.67;95% CI = 1.41-15.38) than late-onset disease. HBV carriers with 20 or fewer AR-CAG repeats and higher testosterone levels had a four-fold increase in HCC risk compared with those with more than 24 repeats and testosterone levels in the lowest tertile. Conclusions: Higher levels of androgen signaling, reflected by higher testosterone levels and 20 or fewer AR-CAG repeats, may be associated with an increased risk of HBV-related HCC in men.

Original language	English
Pages (from-to)	2023-2028
Number of pages	6
Journal	Journal of the National Cancer Institute
Volume	92
Issue number	24
DOIs	https://doi.org/10.1093/jnci/92.24.2023
State	Published - 20 12 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jnci/92.24.2023

Cite this

Yu, M. W., Cheng, S. W., Lin, M. W., Yang, S. Y., Liaw, Y. F., Chang, H. C., Hsiao, T. J., Lin, S. M., Lee, S. D., Chen, P. J., Liu, C. J., & Chen, C. J. (2000). Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. Journal of the National Cancer Institute, 92(24), 2023-2028. https://doi.org/10.1093/jnci/92.24.2023

@article{255560f306354657a0ebc749e98cf389,

title = "Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma",

abstract = "Background: Worldwide, hepatocellular carcinoma (HCC) is more prevalent in men than in women, suggesting that sex hormones and/or X-chromosome-linked genes may be involved in hepatocarcinogenesis. We investigated the association of a trinucleotide (CAG) repeat in the androgen receptor (AR) gene (located on the X chromosome) termed {"}AR-CAG repeats,{"} levels of plasma testosterone, and the risk of HCC in Taiwanese men. Chronic hepatitis B virus (HBV) infection, which is associated with risk of HCC, is hyperendemic in Taiwan. Methods: We compared the number of AR-CAG repeats in 285 HBV carriers with HCC and in 349 HBV carriers without HCC. We also conducted a nested case-control study on participants in a cohort study. Blood was collected prospectively from 110 case patients and 239 control subjects and was used to determine the number of AR-CAG repeats and plasma testosterone level. All statistical tests were two-sided. Results: The overall odds ratio (OR) for HCC was 1.72 (95% confidence interval [CI] = 1.03-2.89) for HBV carriers with 20 or fewer AR-CAG repeats compared with those with more than 24 repeats. This association was observed only in patients with late-onset HCC (OR = 2.37; 95% CI = 1.28-4.38). In the nested case-control study, HBV carriers in the highest tertile of testosterone levels had a statistically significantly increased risk of HCC (OR = 2.06; 95% CI = 1.14-3.70) compared with those in the lowest tertile. Elevated testosterone was more strongly associated with early-onset (OR = 4.67;95% CI = 1.41-15.38) than late-onset disease. HBV carriers with 20 or fewer AR-CAG repeats and higher testosterone levels had a four-fold increase in HCC risk compared with those with more than 24 repeats and testosterone levels in the lowest tertile. Conclusions: Higher levels of androgen signaling, reflected by higher testosterone levels and 20 or fewer AR-CAG repeats, may be associated with an increased risk of HBV-related HCC in men.",

author = "Yu, {Ming Whei} and Cheng, {Shu Wen} and Lin, {Ming Wei} and Yang, {Shi Yi} and Liaw, {Yun Fan} and Chang, {Hung Chuen} and Hsiao, {Tun Jen} and Lin, {Shi Ming} and Lee, {Shou Dong} and Chen, {Pei Jer} and Liu, {Chun Jen} and Chen, {Chien Jen}",

year = "2000",

month = dec,

day = "20",

doi = "10.1093/jnci/92.24.2023",

language = "英语",

volume = "92",

pages = "2023--2028",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "24",

}

TY - JOUR

T1 - Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma

AU - Yu, Ming Whei

AU - Cheng, Shu Wen

AU - Lin, Ming Wei

AU - Yang, Shi Yi

AU - Liaw, Yun Fan

AU - Chang, Hung Chuen

AU - Hsiao, Tun Jen

AU - Lin, Shi Ming

AU - Lee, Shou Dong

AU - Chen, Pei Jer

AU - Liu, Chun Jen

AU - Chen, Chien Jen

PY - 2000/12/20

Y1 - 2000/12/20

N2 - Background: Worldwide, hepatocellular carcinoma (HCC) is more prevalent in men than in women, suggesting that sex hormones and/or X-chromosome-linked genes may be involved in hepatocarcinogenesis. We investigated the association of a trinucleotide (CAG) repeat in the androgen receptor (AR) gene (located on the X chromosome) termed "AR-CAG repeats," levels of plasma testosterone, and the risk of HCC in Taiwanese men. Chronic hepatitis B virus (HBV) infection, which is associated with risk of HCC, is hyperendemic in Taiwan. Methods: We compared the number of AR-CAG repeats in 285 HBV carriers with HCC and in 349 HBV carriers without HCC. We also conducted a nested case-control study on participants in a cohort study. Blood was collected prospectively from 110 case patients and 239 control subjects and was used to determine the number of AR-CAG repeats and plasma testosterone level. All statistical tests were two-sided. Results: The overall odds ratio (OR) for HCC was 1.72 (95% confidence interval [CI] = 1.03-2.89) for HBV carriers with 20 or fewer AR-CAG repeats compared with those with more than 24 repeats. This association was observed only in patients with late-onset HCC (OR = 2.37; 95% CI = 1.28-4.38). In the nested case-control study, HBV carriers in the highest tertile of testosterone levels had a statistically significantly increased risk of HCC (OR = 2.06; 95% CI = 1.14-3.70) compared with those in the lowest tertile. Elevated testosterone was more strongly associated with early-onset (OR = 4.67;95% CI = 1.41-15.38) than late-onset disease. HBV carriers with 20 or fewer AR-CAG repeats and higher testosterone levels had a four-fold increase in HCC risk compared with those with more than 24 repeats and testosterone levels in the lowest tertile. Conclusions: Higher levels of androgen signaling, reflected by higher testosterone levels and 20 or fewer AR-CAG repeats, may be associated with an increased risk of HBV-related HCC in men.

AB - Background: Worldwide, hepatocellular carcinoma (HCC) is more prevalent in men than in women, suggesting that sex hormones and/or X-chromosome-linked genes may be involved in hepatocarcinogenesis. We investigated the association of a trinucleotide (CAG) repeat in the androgen receptor (AR) gene (located on the X chromosome) termed "AR-CAG repeats," levels of plasma testosterone, and the risk of HCC in Taiwanese men. Chronic hepatitis B virus (HBV) infection, which is associated with risk of HCC, is hyperendemic in Taiwan. Methods: We compared the number of AR-CAG repeats in 285 HBV carriers with HCC and in 349 HBV carriers without HCC. We also conducted a nested case-control study on participants in a cohort study. Blood was collected prospectively from 110 case patients and 239 control subjects and was used to determine the number of AR-CAG repeats and plasma testosterone level. All statistical tests were two-sided. Results: The overall odds ratio (OR) for HCC was 1.72 (95% confidence interval [CI] = 1.03-2.89) for HBV carriers with 20 or fewer AR-CAG repeats compared with those with more than 24 repeats. This association was observed only in patients with late-onset HCC (OR = 2.37; 95% CI = 1.28-4.38). In the nested case-control study, HBV carriers in the highest tertile of testosterone levels had a statistically significantly increased risk of HCC (OR = 2.06; 95% CI = 1.14-3.70) compared with those in the lowest tertile. Elevated testosterone was more strongly associated with early-onset (OR = 4.67;95% CI = 1.41-15.38) than late-onset disease. HBV carriers with 20 or fewer AR-CAG repeats and higher testosterone levels had a four-fold increase in HCC risk compared with those with more than 24 repeats and testosterone levels in the lowest tertile. Conclusions: Higher levels of androgen signaling, reflected by higher testosterone levels and 20 or fewer AR-CAG repeats, may be associated with an increased risk of HBV-related HCC in men.

UR - http://www.scopus.com/inward/record.url?scp=84984550462&partnerID=8YFLogxK

U2 - 10.1093/jnci/92.24.2023

DO - 10.1093/jnci/92.24.2023

M3 - 文章

C2 - 11121465

AN - SCOPUS:84984550462

SN - 0027-8874

VL - 92

SP - 2023

EP - 2028

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 24

ER -

Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this